chr5-149730381-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_ModerateBS2
The NM_133263.4(PPARGC1B):c.39G>T(p.Glu13Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000351 in 1,423,576 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133263.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PPARGC1B | NM_133263.4 | c.39G>T | p.Glu13Asp | missense_variant | 1/12 | ENST00000309241.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PPARGC1B | ENST00000309241.10 | c.39G>T | p.Glu13Asp | missense_variant | 1/12 | 1 | NM_133263.4 | P2 | |
PPARGC1B | ENST00000394320.7 | c.39G>T | p.Glu13Asp | missense_variant | 1/11 | 1 | A2 | ||
PPARGC1B | ENST00000360453.8 | c.39G>T | p.Glu13Asp | missense_variant | 1/11 | 1 | A2 | ||
PPARGC1B | ENST00000461780.1 | n.79G>T | non_coding_transcript_exon_variant | 1/4 | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000351 AC: 5AN: 1423576Hom.: 0 Cov.: 31 AF XY: 0.00000142 AC XY: 1AN XY: 706242
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.39G>T (p.E13D) alteration is located in exon 1 (coding exon 1) of the PPARGC1B gene. This alteration results from a G to T substitution at nucleotide position 39, causing the glutamic acid (E) at amino acid position 13 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at